Show simple item record

dc.contributor.advisorSiam, Mohammad Kawsar Sharif
dc.contributor.authorNabin, Md. Naimur Rahman
dc.date.accessioned2024-07-15T05:58:25Z
dc.date.available2024-07-15T05:58:25Z
dc.date.copyright©2024
dc.date.issued2024-02
dc.identifier.otherID 19346041
dc.identifier.urihttp://hdl.handle.net/10361/23697
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.en_US
dc.descriptionCataloged from the PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 55-60).
dc.description.abstractCytomegalovirus is a virus causing irreversible neurological damage in newborns. In this study, in silico computational method was performed where, as primary protein, Capsid Vertex Component 1 Protein of cytomegalovirus from Uniprot server was selected. Using Vaxijen v2.0 it’s antigenicity (0.5142) & Cytotoxic T lymphocyte,helper T lymphocyte,B cell epitopes was found via NetCTL-1.2, NetMHCIIpan 4.0, Bepipred servers. Helper T lymphocyte epitopes were Screened via IFN, IL-4Pred & IL-10Pred epitopes. For constructing the vaccine, linkers were used. A Biochemical analysis gave potential results. With ProtParam the instability index (34.10), grand average of hydropathy (-0.263) & molecular weight (56399.91 kDa) was predicted. Using AllergenOnline & T3DB, the vaccine was discerned as non-allergen & non-toxic. ProSAweb gave Z-score (-5.95) & SWISS-MODEL generated Ramachandran plots. By C-IMMSIM, desirable responses of immune cells & antibodies in accordance with three doses of the vaccine was analyzed. In vitro, in vivo methods can be done to validate the safety & efficacy of the vaccine.en_US
dc.description.statementofresponsibilityMd. Naimur Rahman Nabin
dc.format.extent74 pages
dc.language.isoenen_US
dc.publisherBrac Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectCytomegalovirusen_US
dc.subjectMulti-epitope vaccineen_US
dc.subjectCapsid vertex component 1en_US
dc.subjectBiochemical analysisen_US
dc.subject.lcshCytomegalovirus infections--Treatment
dc.titleIn silico design of a capsid vertex component 1 protein targeted multi-epitope vaccine against cytomegalovirusen_US
dc.typeThesisen_US
dc.contributor.departmentSchool of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record